1ESZ
| STRUCTURE OF THE PERIPLASMIC FERRIC SIDEROPHORE BINDING PROTEIN FHUD COMPLEXED WITH COPROGEN | 分子名称: | COPROGEN, FERRICHROME-BINDING PERIPLASMIC PROTEIN | 著者 | Clarke, T.E, Braun, V, Winkelmann, G, Tari, L.W, Vogel, H.J. | 登録日 | 2000-04-11 | 公開日 | 2002-04-17 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | X-ray crystallographic structures of the Escherichia coli periplasmic protein FhuD bound to hydroxamate-type siderophores and the antibiotic albomycin. J.Biol.Chem., 277, 2002
|
|
1K7S
| FhuD complexed with albomycin-delta 2 | 分子名称: | DELTA-2-ALBOMYCIN A1, Ferrichrome-binding periplasmic protein | 著者 | Clarke, T.E, Braun, V, Winkelmann, G, Tari, L.W, Vogel, H.J. | 登録日 | 2001-10-21 | 公開日 | 2002-04-17 | 最終更新日 | 2023-08-16 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | X-ray crystallographic structures of the Escherichia coli periplasmic protein FhuD bound to hydroxamate-type siderophores and the antibiotic albomycin. J.Biol.Chem., 277, 2002
|
|
1EFD
| PERIPLASMIC FERRIC SIDEROPHORE BINDING PROTEIN FHUD COMPLEXED WITH GALLICHROME | 分子名称: | FERRICHROME-BINDING PERIPLASMIC PROTEIN, GALLICHROME | 著者 | Clarke, T.E, Ku, S.-Y, Dougan, D.R, Vogel, H.J, Tari, L.W. | 登録日 | 2000-02-07 | 公開日 | 2000-04-05 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | The structure of the ferric siderophore binding protein FhuD complexed with gallichrome. Nat.Struct.Biol., 7, 2000
|
|
1K2V
| E. COLI PERIPLASMIC PROTEIN FHUD COMPLEXED WITH DESFERAL | 分子名称: | DEFEROXAMINE MESYLATE FE(III) COMPLEX, Ferrichrome-binding periplasmic protein | 著者 | Clarke, T.E, Braun, V, Winkelmann, G, Tari, L.W, Vogel, H.J. | 登録日 | 2001-09-29 | 公開日 | 2002-04-17 | 最終更新日 | 2023-08-16 | 実験手法 | X-RAY DIFFRACTION (1.97 Å) | 主引用文献 | X-ray crystallographic structures of the Escherichia coli periplasmic protein FhuD bound to hydroxamate-type siderophores and the antibiotic albomycin. J.Biol.Chem., 277, 2002
|
|
4FS3
| Crystal structure of Staphylococcus aureus enoyl-ACP reductase in complex with NADP and AFN-1252 | 分子名称: | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI, N-methyl-N-[(3-methyl-1-benzofuran-2-yl)methyl]-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)propanamide, [[(2R,3S,4R,5R)-5-(3-aminocarbonyl-4H-pyridin-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methyl hydrogen phosphate | 著者 | Kaplan, N, Yethon, J, Bardouniotis, E, Thalakada, R, Albert, M, Awrey, D.E, Romanov, V, Dorsey, M, Ramnauth, J, Clarke, T.E, Schmid, M.B, Berman, J, Pauls, H.W. | 登録日 | 2012-06-26 | 公開日 | 2012-09-19 | 最終更新日 | 2023-09-13 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor. Antimicrob.Agents Chemother., 56, 2012
|
|